惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Hugging Face - Blog
Hugging Face - Blog
云风的 BLOG
云风的 BLOG
Google DeepMind News
Google DeepMind News
美
美团技术团队
J
Java Code Geeks
V
V2EX
钛媒体：引领未来商业与生活新知
钛媒体：引领未来商业与生活新知
The Cloudflare Blog
宝玉的分享
宝玉的分享
博
博客园 - Franky
Y
Y Combinator Blog
爱范儿
爱范儿
H
Help Net Security
腾
腾讯CDC
G
Google Developers Blog
B
Blog RSS Feed
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
阮一峰的网络日志
阮一峰的网络日志
罗
罗磊的独立博客
V
Visual Studio Blog
The GitHub Blog
The GitHub Blog
博
博客园_首页
C
Check Point Blog
博
博客园 - 三生石上(FineUI控件)

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Cytokinetics, Incorporated (CYTK) Discusses ACACIA-HCM To...
2026-05-06 · via All Articles on Seeking Alpha

Cytokinetics, Incorporated (CYTK) Discusses ACACIA-HCM Topline Results From Pivotal Phase 3 Trial of Aficamten in Non-Obstructive HCM May 5, 2026 8:00 AM EDT

Company Participants

Diane Weiser - Senior Vice President of Corporate Affairs
Robert I. Blum - CEO, President & Director
Fady Malik - Executive Vice President of Research & Development
Stephen Heitner - Senior Vice President of Clinical Research & Development
Stuart Kupfer - Senior VP & Chief Medical Officer

Conference Call Participants

Salim Syed - Mizuho Securities USA LLC, Research Division
Roanna Clarissa Ruiz - Leerink Partners LLC, Research Division
Tessa Romero - JPMorgan Chase & Co, Research Division
Maxwell Skor - Morgan Stanley, Research Division
Mayank Mamtani - B. Riley Securities, Inc., Research Division
Leonid Timashev - RBC Capital Markets, Research Division
Srikripa Devarakonda - Truist Securities, Inc., Research Division
Ashwani Verma - UBS Investment Bank, Research Division
Kyuwon Choi - Goldman Sachs Group, Inc., Research Division
Carter Gould - Cantor Fitzgerald & Co., Research Division
James Condulis - Stifel, Nicolaus & Company, Incorporated, Research Division
Jason Butler - Citizens JMP Securities, LLC, Research Division
Martin Auster - Raymond James & Associates, Inc., Research Division
Cory Kasimov - Evercore ISI Institutional Equities, Research Division
Serge Belanger - Needham & Company, LLC, Research Division
Jason Zemansky - BofA Securities, Research Division
Yanan Zhu - Wells Fargo Securities, LLC, Research Division

Presentation

Operator

Thank you for standing by, and welcome to Cytokinetics' conference call to discuss the top line results of ACACIA-HCM. This call is being recorded. [Operator Instructions].

I would now like to turn the conference over to Diane Weiser, Cytokinetics' Senior Vice President of Corporate Affairs. Please go ahead.

Diane Weiser
Senior Vice President of Corporate Affairs

Good morning, and thanks for joining us on the call today. Robert Blum, President and Chief Executive Officer, will begin with a brief introduction. Then Fady Malik, EVP of R&D, will provide an overview of the top line data from ACACIA-HCM. Stuart Kupfer, SVP, Chief Medical Officer; and

此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。